Showing 6031-6040 of 7243 results for "".
- Menlo Therapeutics to Present Late-Breaking Oral Presentation at AAD Annual Meetinghttps://practicaldermatology.com/news/menlo-therapeutics-to-present-late-breaking-oral-presentation-at-aad-annual-meeting/2459917/Menlo Therapeutics Inc., a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus, has had its abstract accepted for oral presentation at the Late-Breaking Research Program during the 2019 Annual Meeting in Washington, DC. The ab
- 2019 Residents of Distinction Return from Caribbean Dermatology Symposiumhttps://practicaldermatology.com/news/2019-residents-of-distinction-return-from-caribbean-dermatology-symposium/2459919/Five dermatology residents have just returned from the 18th Annual Caribbean Dermatology Symposium, held in Grand Cayman Island. Their participation was sponsored by Beiersdorf Inc., as part of the dermMentors™ Resident of Distinction Award™ program. The reside
- Merz and Christie Brinkley Partner to Launch “Milestones of Me” Campaignhttps://practicaldermatology.com/news/merz-and-christie-brinkley-partner-to-launch-milestones-of-me-campaign/2459922/Merz Americas is partnering with supermodel, actress, and entrepreneur, Christie Brinkley, to launch its “Milestones of Me” campaign, which encourages women to celebrate the moments, big or small, that have made them who they are today. The campaign, which kicks off in honor of Christ
- Keloids May Up Breast Cancer Riskhttps://practicaldermatology.com/news/keloids-may-up-breast-cancer-risk/2459925/Keloids may be associated with an increased risk breast cancer, particularly among African Americans, a new study suggests. The research team hypothesized African American women with a history of keloids would reflect a population of breast cancer patients with aggressive tumors and poor
- Alan Menter, MD Receives Outstanding Researcher and Educator in Psoriatic Disease Award from ODAC, JDDhttps://practicaldermatology.com/news/alan-menter-md-receives-outstanding-researcher-and-educator-in-psoriatic-disease-award-from-odacjdd/2459929/Alan Menter, MD, has been awarded the Outstanding Researcher and Educator in Psoriatic Disease Award by the ODAC Dermatology, Aesthetics & Surgical Conference, in partnership with the Journal of Drugs in Dermatology (JDD). The award recognizes Dr. Menter’
- Galderma Forms Women In Aesthetics Leadership Councilhttps://practicaldermatology.com/news/galderma-forms-women-in-aesthetics-council/2459928/Galderma Laboratories, L.P. has formed a Women in Aesthetics Leadership Council, comprised of clinicians, clinical trial investigators, CEOs, business owners, and practice managers. "In most industries in the US women hold just 25 percent of senior leadership positions
- Gryphon Acquires Roc Skincare from J & Jhttps://practicaldermatology.com/news/gryphon-acquires-roc-skincare-from-j-j/2459930/Gryphon Investors has acquired RoC Skincare from Johnson & Johnson Consumer, Inc. The transaction is Gryphon's second investment in the beauty sector after the firm acquired indie color cosmet
- Dermatologists Prescribe the Most Antibiotics, But Usage Is Changinghttps://practicaldermatology.com/news/dermatologists-prescribe-the-most-antibiotics-but-usage-is-changing/2459935/The use of antibiotics to treat inflammatory skin conditions like acne and rosacea is decreasing over time, but there has been an increase in prescriptions associated with dermatologic surgical procedures, a new study finds. The study appears in
- L'Occitane to Buy ELEMIS for $900 Millionhttps://practicaldermatology.com/news/loccitane-to-buy-elemis-for-900-million/2459939/L’Occitane International S.A. has entered into a definitive agreement to acquire ELEMIS, the number one luxury British skincare brand, for $900 million in cash. ELEMIS is being sold by Steiner Leisure Limited. Reinold Geiger, Chairman and Chief Executive Officer of L’OCCITANE
- LEO Pharma Focuses on Translational Medicine, Appoints Dr. Adam B. Raff as Director & Medical Advisorhttps://practicaldermatology.com/news/leo-pharma-strengthens-focus-on-translational-medicine-with-appointment-of-dr-adam-b-raff-as-director-medical-advisor/2459942/LEO Pharma has appointed Adam B. Raff, MD, PhD as Director and Medical Advisor in Translational Medicine, effective January 28. Dr. Raff’s primary objective will be to support LEO Pharma’s ambitions to advance science within dermatology through translational medicine, the company says